Indeed, under TLR9 activation in vivo, anti-DNA Carabin−/− B cells were producing autoantibodies, leading to the development of a disease similar to mesangial type II lupus glomerulonephritis (ISN/RPS classification of lupus nephritis) with a incomplete prevalence. This evidence concerns the gene TLR9 and lupus nephritis.